Long Non-Coding RNA LINC00511 Mediates the Effects of ESR1 on Proliferation and Invasion of Ovarian Cancer Through miR-424-5p and miR-370-5p

References

• Romero I, Bast RC Jr. Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology. 2012;153(4 ):1593–1602. doi:10.1210/en.2011-212322416079
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1 ):7–34. doi:10.3322/caac.v69.130620402
   PubMed Web of Science ®Google Scholar
• Modugno F, Laskey R, Smith AL, Andersen CL, Haluska P, Oesterreich S. Hormone response in ovarian cancer: time to reconsider as a clinical target? Endocr Relat Cancer. 2012;19(6 ):R255–279. doi:10.1530/ERC-12-017523045324
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93(12 ):5925–5930. doi:10.1073/pnas.93.12.59258650195
   PubMed Web of Science ®Google Scholar
• Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996;392(1 ):49–53. doi:10.1016/0014-5793(96)00782-X8769313
   PubMed Web of Science ®Google Scholar
• Li S, Li Y, Wen Z, Kong F, Guan X, Liu W. microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor alpha-positive ovarian cancer cells. Mol Med Rep. 2014;9(5 ):1703–1708. doi:10.3892/mmr.2014.202124604205
   PubMed Web of Science ®Google Scholar
• Wang S, Li X, Zhang W, et al. Genome-wide investigation of genes regulated by ERalpha in breast cancer cells. Molecules. 2018;23:10.
   Web of Science ®Google Scholar
• Wang Y, Lu Y, Li Z, et al. Oestrogen receptor alpha regulates the odonto/osteogenic differentiation of stem cells from apical papilla via ERK and JNK MAPK pathways. Cell Prolif. 2018;51(6 ):e12485. doi:10.1111/cpr.1248530069950
   PubMed Web of Science ®Google Scholar
• Peng Z, Zhang C, Duan C. Functions and mechanisms of long noncoding RNAs in lung cancer. Onco Targets Ther. 2016;9:4411–4424. doi:10.2147/OTT.S10954927499635
   PubMed Web of Science ®Google Scholar
• Zuo Y, Li Y, Zhou Z, Ma M, Fu K. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer. Biomed Pharmacother. 2017;95:922–928. doi:10.1016/j.biopha.2017.09.00528915533
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao W, Wang Z, Xiang X, Zhang S, Liu L. Long non-coding RNA SNHG20 promotes the tumorigenesis of oral squamous cell carcinoma via targeting miR-197/LIN28 axis. J Cell Mol Med. 2019;23(1 ):680–688. doi:10.1111/jcmm.2019.23.issue-130394668
   PubMed Web of Science ®Google Scholar
• Zou MF, Ling J, Wu QY, Zhang CX. Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2. Eur Rev Med Pharmacol Sci. 2018;22(21 ):7183–7188. doi:10.26355/eurrev_201811_1625130468460
   PubMed Web of Science ®Google Scholar
• Liu X, Wen J, Wang H, Wang Y. Long non-coding RNA LINC00460 promotes epithelial ovarian cancer progression by regulating microRNA-338-3p. Biomed Pharmacother. 2018;108:1022–1028. doi:10.1016/j.biopha.2018.09.10330372802
   PubMed Web of Science ®Google Scholar
• Hu HB, Chen Q, Ding SQ. LncRNA LINC01116 competes with miR-145 for the regulation of ESR1 expression in breast cancer. Eur Rev Med Pharmacol Sci. 2018;22(7 ):1987–1993. doi:10.26355/eurrev_201804_1472629687853
   PubMed Web of Science ®Google Scholar
• Toderow V, Rahmeh M, Hofmann S, et al. Promotor analysis of ESR1 in endometrial cancer cell lines, endometrial and endometriotic tissue. Arch Gynecology Obstetrics. 2017;296(2 ):1–8. doi:10.1007/s00404-017-4405-x
   PubMed Web of Science ®Google Scholar
• Czogalla B, Kahaly M, Mayr D, et al. Interaction of ERα and NRF2 impacts survival in ovarian cancer patients. Int J Mol Sci. 2018;20(1 ):E112. doi:10.3390/ijms2001011230597961
   PubMed Web of Science ®Google Scholar
• Lu G, Li Y, Ma Y, et al. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res. 2018;37(1 ):289. doi:10.1186/s13046-018-0945-630482236
   PubMedGoogle Scholar
• Ding J, Yang C, Yang S. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2. J Oral Pathol Med. 2018;47(5 ):468–476. doi:10.1111/jop.2018.47.issue-529315846
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu Y, Li Z, et al. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. J Cell Mol Med. 2018;22(1 ):655–667. doi:10.1111/jcmm.2018.22.issue-128984028
   PubMed Web of Science ®Google Scholar
• Sun CC, Li SJ, Li G, Hua RX, Zhou XH, Li DJ. Long intergenic noncoding RNA 00511 acts as an oncogene in non-small-cell lung cancer by binding to EZH2 and suppressing p57. Mol Ther Nucleic Acids. 2016;5(11 ):e385. doi:10.1038/mtna.2016.9427845772
   PubMedGoogle Scholar
• Hua F, Li CH, Chen XG, Liu XP. Long noncoding RNA CCAT2 knockdown suppresses tumorous progression by sponging miR-424 in epithelial ovarian cancer. Oncol Res. 2018;26(2 ):241–247. doi:10.3727/096504017X1495394867541228550684
   PubMed Web of Science ®Google Scholar
• Wu X, Ruan Y, Jiang H, Xu C. MicroRNA-424 inhibits cell migration, invasion, and epithelial mesenchymal transition by downregulating doublecortin-like kinase 1 in ovarian clear cell carcinoma. Int J Biochem Cell Biol. 2017;85:66–74. doi:10.1016/j.biocel.2017.01.02028161486
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang J, He Y, Wang Y. hsa_circ_0061140 knockdown reverses FOXM1-mediated cell growth and metastasis in ovarian cancer through miR-370 sponge activity. Mol Ther Nucleic Acids. 2018;8:22.
   Google Scholar